Amyotrophic Lateral Sclerosis: all 1,000 studies
Page 7 of 10. Open to participants first (284), then studies with results posted, then the rest; newest registration first within each.
- The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)"CompletedNCT04305639
- HEALEY ALS Platform Trial - Master ProtocolActive, not recruitingNCT04297683Phase 2/3
- Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral SclerosisCompletedNCT04293484Not applicable
- Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT04288856Phase 1
- Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)CompletedNCT04259255
- Evaluation of Palliative Care for Patients With ALS and Their CaregiversCompletedNCT04257760Not applicable
- Mitochondrial Capacity Boost in ALS (MICABO-ALS) TrialActive, not recruitingNCT04244630Phase 2
- Tolerability, Safety and Efficacy of Sigh Breaths During NIMV in Motor Neuron DiseaseStatus unknownNCT04240925Not applicable
- Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS)CompletedNCT04233099
- Breath Stacking Technique Associated With Expiratory Muscle Training in Amyotrophic Lateral Sclerosis PatientsTerminatedNCT04226144Not applicable
- Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT04172792Phase 1
- Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALSCompletedNCT04165850Phase 2
- A Study to Explore the Role of Gut Flora in ALSWithdrawnNCT04150809
- The Efficacy and Safety of Vitamin E Mixed Tocotrienols In Patients With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT04140136Phase 2
- The Ontario Neurodegenerative Disease Research InitiativeCompletedNCT04104373
- Ciprofloxacin/Celecoxib Combination in Patients With ALSCompletedNCT04090684Phase 1
- CuATSM Compared With Placebo for Treatment of ALS/MNDStatus unknownNCT04082832Phase 2/3
- Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALSActive, not recruitingNCT04057898Phase 2/3
- T-regulatory Cells in ALSStatus unknownNCT04055623Phase 2
- Biomarkers in Neurodegenerative DiseasesWithdrawnNCT04055532
- The E-health Application To Modify ORal Energy Intake and Measure Outcomes REmotely in ALS Clinical Trial (EAT MORE2)CompletedNCT04051333
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
- Real World Testing of a Brain-Computer InterfaceCompletedNCT04026581
- New Therapeutic Strategy in ALS Based on Metabolic Status and Associated Metabolic Pathways.CompletedNCT03984708Not applicable
- A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT03981536Phase 1
- Psychological Therapy for Patients With ALSCompletedNCT03975608Not applicable
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral SclerosisCompletedNCT03945279Phase 1
- Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral SclerosisCompletedNCT03929068Phase 1
- TRIAL READY (Clinical Trial Readiness)Active, not recruitingNCT03912987
- Restore Motor Function Through Robotic Arm Exoskeleton and Brain Computer InterfaceStatus unknownNCT03900247Not applicable
- Repetitive Transcranial Magnetic Stimulation as Therapy for Depression in Amyotrophic Lateral SclerosisWithdrawnNCT03892863Not applicable
- Repetitive Transcranial Magnetic Stimulation as Therapy for Apathy in Amyotrophic Lateral SclerosisWithdrawnNCT03892382Not applicable
- Systematic Laryngoscopic Evaluation of Upper Airways in Ventilated ALS Patients in Portugal and in NorwayStatus unknownNCT03887338Not applicable
- Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PETCompletedNCT03876002Phase 1
- Speech Analysis in ALS PatientsCompletedNCT03868345
- 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)WithdrawnNCT03843710Phase 2
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral SclerosisCompletedNCT03828123Phase 1/2
- [BrainConnexion] - Neurodevice Phase I TrialStatus unknownNCT03811301Not applicable
- Serial Fasciculation Measurements in Motor Neurone DiseaseCompletedNCT03809845Not applicable
- Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1)Status unknownNCT03806647
- Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2)Status unknownNCT03806634
- Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALSActive, not recruitingNCT03800524Phase 3
- Perampanel Single Ascending Dose Transcranial Magnetic Stimulation Biomarker Study in Amyotrophic Lateral SclerosisCompletedNCT03793868Early Phase 1
- Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALSCompletedNCT03792490Phase 2
- Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS.Status unknownNCT03787420Not applicable
- Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis PatientsCompletedNCT03766321Not applicable
- Validation Of Tidal/End -Tidal CO2 in ALSStatus unknownNCT03764384
- Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral SclerosisTerminatedNCT03757351Phase 1
- A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IVSuspendedNCT03755167Phase 2
- Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE StudyCompletedNCT03707795Early Phase 1
- Study of ALS Reversals 4: LifeTime ExposuresCompletedNCT03706391
- Brain Excitability and Connectivity in Sensory-motor Pathways in ALSCompletedNCT03694132Not applicable
- Colchicine for Amyotrophic Lateral SclerosisCompletedNCT03693781Phase 2
- Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone DiseaseStatus unknownNCT03690791Phase 3
- Ultrasonography of the Neuromuscular Degeneration Behavior in Amyotrophic Lateral SclerosisCompletedNCT03683875
- Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance SpectroscopyWithdrawnNCT03664206
- Dietary Approach to Improving Quality of Life in Amyotrophic Lateral SclerosisWithdrawnNCT03659422Not applicable
- A Study of IPL344 in the Treatment of ALS PatientsSuspendedNCT03652805Phase 1/2
- To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy VolunteersActive, not recruitingNCT03651349Phase 1
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral SclerosisCompletedNCT03626012Phase 1
- Neuromuscular Magnetic Stimulation in ALS PatientsCompletedNCT03618966Phase 2
- A Study to Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral SclerosisTerminatedNCT03613571Phase 2
- A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive DysarthriaCompletedNCT03613038Not applicable
- Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALSStatus unknownNCT03604822Not applicable
- Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation StudyCompletedNCT03579017
- Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort StudyCompletedNCT03578796
- Presymptomatic Neuromuscular Junction Defects and Compensatory Mechanisms in ALSStatus unknownNCT03573466Not applicable
- Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03560661
- Clinical Trial of Ultra-high Dose Methylcobalamin for ALSCompletedNCT03548311Phase 3
- Neurofeedback Rehabilitation Based on Motor Imaging in Patients in the Immobilization PhaseStatus unknownNCT03545451Not applicable
- Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)No longer availableNCT03537807
- Multidisciplinary Follow-up of Patients With Amyotrophic Lateral SclerosisStatus unknownNCT03536962
- Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALSCompletedNCT03520517Phase 1
- A Pilot Study of the Utility of 3D Printed Masks for ALS SubjectsTerminatedNCT03519880Not applicable
- Reducing Disparities in the Quality of Advance Care Planning for Older AdultsCompletedNCT03516994Not applicable
- IC14 for Treatment of Amyotrophic Lateral SclerosisWithdrawnNCT03508453Phase 2
- EH301 for the Treatment of ALSCompletedNCT03489200Not applicable
- Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone DiseaseCompletedNCT03487263Phase 1
- A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03482050Phase 1/2
- Pharyngeal Electrical Stimulation in Amyotrophic Lateral SclerosisCompletedNCT03481348Phase 1/2
- IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT03474263Phase 2
- Study of ALS Reversals 2: Genetic AnalysesCompletedNCT03464903
- Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral SclerosisWithdrawnNCT03457753Phase 2
- Predictive Factors for the Diagnosis of Early Noninvasive Ventilation EquipmentStatus unknownNCT03452618Not applicable
- SOD1 Kinetics Measurements in ALS PatientsSuspendedNCT03449212
- The Relationship Between Arterial Stiffness and Respiratory Failure in Motor Neurone DiseaseCompletedNCT03444428
- Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral SclerosisCompletedNCT03427086Phase 2
- Hypermetabolism in ALS Using Six REE FormulasCompletedNCT03382392
- Resting Energy Expenditure Equations in Amyotrophic Lateral Sclerosis, Creation of a ALS-specific EquationCompletedNCT03378375
- Optic Coherence Tomography in Patients With Amyotrophic Lateral SclerosisStatus unknownNCT03377868Not applicable
- Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis PatientsTerminatedNCT03377309Phase 2
- Epidemiology and Genetics of the Amyotrophic Lateral Sclerosis in the French West IndiesStatus unknownNCT03367650Not applicable
- Novel MRI Biomarkers for Monitoring Disease Progression in ALSActive, not recruitingNCT03362658
- Rapamycin Treatment for ALSCompletedNCT03359538Phase 2
- The General Breathing Record StudyCompletedNCT03356288
- Study to Evaluate the Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Upper or Lower Extremity Muscles Most Affected in Subjects With ALSWithdrawnNCT03338114Phase 1/2
- Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALSTerminatedNCT03334786Phase 1/2
- Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear PalsyStatus unknownNCT03330353
- Exercise and Disease Progression in Amyotrophic Lateral Sclerosis PatientsCompletedNCT03326622Not applicable